Skip to Main content Skip to Navigation
Journal articles

Glutaminolysis and autophagy in cancer

Abstract : The remarkable metabolic differences between cancer cells and normal cells result in the potential for targeted cancer therapy. The upregulation of glutaminolysis provides energetic advantages to cancer cells. The recently described link between glutaminolysis and autophagy, mediated by MTORC1, may constitute an attractive target for therapeutic strategies. A combination of therapies targeting simultane-ously cell signaling, cancer metabolism, and autophagy can solve therapy resistance and tumor relapse problems, commonly observed in patients treated with most of the current targeted therapies. In this review we summarize the mechanistic link between glutaminolysis and autophagy, and discuss the impacts of these processes on cancer progression and the potential for therapeutic intervention.
Document type :
Journal articles
Complete list of metadata

https://www.hal.inserm.fr/inserm-03653052
Contributor : Mojgan Djavaheri-Mergny Connect in order to contact the contributor
Submitted on : Wednesday, April 27, 2022 - 12:30:39 PM
Last modification on : Wednesday, May 4, 2022 - 3:04:17 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Victor Villar, Faten Merhi, Mojgan Djavaheri-Mergny, Raúl Durán. Glutaminolysis and autophagy in cancer. Autophagy, Taylor & Francis, 2015, 11 (8), pp.1198-1208. ⟨10.1080/15548627.2015.1053680⟩. ⟨inserm-03653052⟩

Share

Metrics

Record views

2